Literature DB >> 25190348

MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells.

Magdalene Ameka1, Michael P Kahle1, Mathew Perez-Neut1, Saverio Gentile1, Ahmed A Mirza1, Bruce D Cuevas1.   

Abstract

The intracellular kinase MEKK2 (mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase kinase 2) is an upstream regulator of JNK (c-Jun N-terminal kinase), but additional functions for MEKK2 have not been well defined. Silencing MEKK2 expression in invasive breast tumour cells markedly inhibits xenograft metastasis, indicating that MEKK2 controls tumour cell function required for tumour progression. In our previous investigation of MEKK2 function, we discovered that tumour cell attachment to fibronectin recruits MEKK2 to focal adhesion complexes, and that MEKK2 knockdown is associated with stabilized focal adhesions and significant inhibition of tumour cell migration. In the present study we investigate MEKK2 function in focal adhesions and we report that MEKK2 physically associates with the LD1 motif of the focal adhesion protein paxillin. We reveal that MEKK2 induces paxillin ubiquitylation, and that this function requires both the paxillin LD1 motif and MEKK2 kinase activity. Finally, we demonstrate that MEKK2 promotes paxillin redistribution from focal adhesions into the cytoplasm, but does not promote paxillin degradation. Taken together, our results reveal a novel function for MEKK2 as a regulator of ubiquitylation-dependent paxillin redistribution in breast tumour cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25190348      PMCID: PMC4467534          DOI: 10.1042/BJ20140420

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  Cell movements during vertebrate development: integrated tissue behaviour versus individual cell migration.

Authors:  A Locascio; M A Nieto
Journal:  Curr Opin Genet Dev       Date:  2001-08       Impact factor: 5.578

2.  Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways.

Authors:  James A Witowsky; Gary L Johnson
Journal:  J Biol Chem       Date:  2002-11-26       Impact factor: 5.157

3.  MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts.

Authors:  Bruce D Cuevas; Amy N Abell; James A Witowsky; Toshiaki Yujiri; Nancy Lassignal Johnson; Kamala Kesavan; Marti Ware; Peter L Jones; Scott A Weed; Roberta L DeBiasi; Yoshitomo Oka; Kenneth L Tyler; Gary L Johnson
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

4.  Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions.

Authors:  S N Nikolopoulos; C E Turner
Journal:  J Biol Chem       Date:  2001-04-13       Impact factor: 5.157

5.  MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation.

Authors:  T Yujiri; M Ware; C Widmann; R Oyer; D Russell; E Chan; Y Zaitsu; P Clarke; K Tyler; Y Oka; G R Fanger; P Henson; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

6.  MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.

Authors:  Weiyong Sun; Xudong Wei; Kamala Kesavan; Timothy P Garrington; Ruihua Fan; Junjie Mei; Steven M Anderson; Erwin W Gelfand; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  JNK phosphorylates paxillin and regulates cell migration.

Authors:  Cai Huang; Zenon Rajfur; Christoph Borchers; Michael D Schaller; Ken Jacobson
Journal:  Nature       Date:  2003-07-10       Impact factor: 49.962

8.  Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction.

Authors:  Zijian Guo; Gavin Clydesdale; Jinke Cheng; Kihwan Kim; Lin Gan; David J McConkey; Stephen E Ullrich; Yuan Zhuang; Bing Su
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells.

Authors:  Ahmed A Mirza; Michael P Kahle; Magdalene Ameka; Edward M Campbell; Bruce D Cuevas
Journal:  Biochim Biophys Acta       Date:  2014-01-31

Review 10.  Integrin cytoplasmic domain-binding proteins.

Authors:  S Liu; D A Calderwood; M H Ginsberg
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

View more
  5 in total

Review 1.  Oncogenic signaling of MEK5-ERK5.

Authors:  Van T Hoang; Thomas J Yan; Jane E Cavanaugh; Patrick T Flaherty; Barbara S Beckman; Matthew E Burow
Journal:  Cancer Lett       Date:  2017-01-30       Impact factor: 8.679

2.  Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2).

Authors:  Syed Ahmad; Valentine R St Hilaire; Srinivasa R Dandepally; Gary L Johnson; Alfred L Williams; John E Scott
Journal:  Biochem Biophys Res Commun       Date:  2018-01-05       Impact factor: 3.575

3.  Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity.

Authors:  Syed Ahmad; Gary L Johnson; John E Scott
Journal:  Biochem Biophys Res Commun       Date:  2015-06-06       Impact factor: 3.575

4.  Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto-inhibition.

Authors:  Michael P Kahle; Bruce D Cuevas
Journal:  J Mol Signal       Date:  2015-10-16

5.  Silencing of the MEKK2/MEKK3 Pathway Protects against Spinal Cord Injury via the Hedgehog Pathway and the JNK Pathway.

Authors:  Yan-Long Kong; Yi-Fei Wang; Zhong-Sheng Zhu; Zheng-Wei Deng; Jing Chen; Dong Zhang; Qun-Hua Jiang; Shi-Chang Zhao; Ya-Dong Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2019-06-04       Impact factor: 8.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.